2024 Agenda at a Glance

Monday, September 2, 2024
Registration & Badge Pick Up	4:00 PM - 8:00 PM
Private Meeting Rooms Open	4:00 PM - 8:00 PM
Drinks at Lobby Bar	4:00 PM - 10:00 PM

Tuesday, September 3, 2024
Exhibitor Set up	11:00 AM - 8:00 PM
Exhibitor Halls Open	1:00 PM - 5:00 PM
Private Meeting Rooms Open	11:00 AM - 8:00 PM
Registration & Badge Pick Up	9:00 AM - 8:00 PM
Workshop A: CMC Strategies for Small Molecule Biotech & Emerging BioPharma: Getting Your Compound into Clinic & Supplier Selection	1:00 PM - 4:00 PM
Deb Minor President Drug Discovery Alliances Jim Bruno Principal Chemical and Pharmaceutical Solutions Sean Bradley Vice President of Business Development GL Chemtec International Ltd.
Workshop B: Effective CDMO Proposals for Sponsors: Terms, Milestones, Royalty Payments, Dates, Project Management	1:00 PM - 4:00 PM
Malcolm Rosenthal Consultant Phlow Corp Robert Miller Consultant AbbVie (Retired) George Regan Consultant Pfizer (Retired)
Workshop C: FDA Now Approving Generic GLP-1 Peptides & Biosimilar Insulin: Regulatory Strategies	2:00 PM - 5:00 PM
Robert Geiger, Ph.D Senior Director of Business Development Juizhou Pharmaceutical Co
Workshop D: Leveraging Data and AI to Optimize Manufacturing Operations	3:00 PM - 3:45 PM
Dino Dedic Senior Managing Director Guggenheim Securities Pep Gubau CEO Aizon Scott Waldman Managing Member Waldman Growth Strategies
What's Going On with Demand for CDMO Services?	4:00 PM - 4:45 PM
Brian Scanlan Operating Partner, Life Sciences Edgewater Capital Nick Bell Managing Director, Pharma Services Baird Global Healthcare Investment Banking Chris Conway CEO BioXcell Lisa Studnicki Co-Founder, COO GL Chemtec Ray Forslund Senior VP, CMC SynerG Consulting Ramesh Subramanian Global CEO PI Health Sciences
Casino Night Party	5:30 PM - 8:30 PM
After Party Drinks at Lobby Bar	9:00 PM - ?

Wednesday, September 4, 2024
Private Meeting Rooms Open	7:00 AM - 6:00 PM
Registration and Badge Pickup	7:00 AM - 8:00 PM
Exhibit Halls Open	7:30 AM - 6:00 PM
Exhibitor Presentations	9:00 AM - 5:00 PM
China CDMO Business Growth Forecast 2025	9:00 AM - 9:45 AM
Keith Dodson Executive Dir Business Development Porton Pharma Solutions Steve Beagle Principal Pharmeagle Partners Consulting Victor Li Head of BD for North American Region Apeloa Pharma Dennis Murachanian Principal 818 Pharmaceutical Consulting Jim Bruno Principal Chemical and Pharmaceutical Solutions Roger Laforce Managing Director DORRA EUROPE Brian Treco Vice President, Business Development Agno Pharma Oliver Hughes Managing Consultant Harris & Co Executive Search Francis Gibson Executive Search Consultant Harris & Co Executive Search
Keynote - USA 2024 Post-Election Healthcare Investment: What's Next?	10:30 AM - 11:30 AM
Stefan Loren, Ph.D. Managing Director, Healthcare Investment Banking Oppenheimer
Luncheon	12:30 PM - 1:45 PM
Structured Approach to Using a Target Product Profile to Develop a DP Development Strategy	1:45 PM - 2:30 PM
Hugh Huang Vice President, Drug Product R&D J-Star Research, Inc. Ray Sison Managing Partner SCxCMC LLC Ronald Vladyka Director, Drug Product GMP Operations J-STAR Research, Inc.
GLP-1-Based Therapeutics Sourcing: Supply Chain Challenges	3:30 PM - 4:15 PM
Robert Geiger (Moderator) Senior Director of Business Development Jiuzhou Pharmaceuticals/ Raybow USA Trishul Shah (Panel) Director Global Sales and Marketing PolyPeptide Group John Phipps (Panel) Vice President of Clinical Pipeline Development CPC Scientific Colin Smith Pharma Innovation Leader Aurorium Rob Camerer (Panel) CEO Global Pharma Partners Tim Nieters Senior VP of Strategic Portfolio Development CPC Scientific
Venture Capital Healthcare Investment: 2025 Forecast	4:15 PM - 5:00 PM
Stefan Loren Managing Director Healthcare Investment Banking Oppenheimer Nigel Walker CEO That's Nice Ankit Aggarwal VP Healthcare Investment Banking JP Morgan Kareem Ali Vice President Investment Banking Alliance Global Partners
Casino Night II, Games, Karoake, Dinner & Drinks	5:30 PM - 9:00 PM
Drinks at Lobby Bar	8:00 PM - 11:00 PM

Thursday, September 5, 2024
Private Meeting Rooms Open	7:00 AM - 6:00 PM
Registration & Badge Pick Up	7:00 AM - 8:00 PM
Exhibit Halls Open	7:30 AM - 6:00 PM
Coffee & Snacks	7:30 AM - 12:00 PM
The Market for New Peptide Therapeutics Is Huge	9:00 AM - 9:45 AM
Jonathan Collins Vice President Business Development CEM Corporation Ray Alsko Director of Business Development Sterling Pharma Solutions Brien McDonough Director of Business Development AnaSpec Mimoun Ayoub Senior VP, Global Head Sales and Key Accounts Corden Pharma Matteo Villain Vice President and Global Peptides Technical Lead Piramal Pharma Solutions Tangqing Li SVP Sinopep-Allsino Biopharmaceutical Co. Robert Bloder Chief Business Officer Ascendia Pharmaceuticals
Update: Latest Commercial Strategy 505(b)(2)	10:30 AM - 11:15 AM
Rob Camerer CEO Global Pharma Partners Robert Bloder Chief Business Officer Ascendia Pharmaceuticals Tushar Nuwal CEO Ligandal TJ Higley CEO Microsize
Luncheon	1:00 PM - 2:15 PM
Small Pharma 2024: What You Need to Do to File an IND	1:45 PM - 2:30 PM
Ken Drew Vice President Flamma USA Masha Koninov National Director of Business Development Ingenza Ltd Jim Bruno Principal Chemical and Pharmaceutical Solutions Anil Kane Global Head of Technical & Scientific Affairs ThermoFisher Scientific Tom Hunter Associate Director, Process Development Millipore Sigma Gangli Gong Senior Director STA Pharmaceutical
ADC/PDCs, Complexities of the Supply Network and Implications for Contract Manufacturers	3:15 PM - 4:00 PM
Derron Stark Partner EY Parthenon Brian Gavin Senior Director EY Parthenon Louise Duffy CTO/CQO Abzena
Flow Chemistry: Current Advances & Challenges	4:00 PM - 4:45 PM
Dom Hebrault Associate Director Process Engineering Veranova Xingren Jiang Business Specialist Jiuzhou Pharma Simon Hickling VP - CDMO Business Developmentt Phlow
Gala Dinner Party	5:30 PM - 8:30 PM
After Party Drinks at Lobby Bar	8:30 PM - 11:00 PM

Friday, September 6, 2024
Private Meeting Rooms Open	7:00 AM - 12:00 PM
Registration & Badge Pick Up	7:00 AM - 12:00 PM
Exhibit Halls Open	7:30 AM - 12:00 PM
Coffee & Snacks	7:30 AM - 12:00 PM
Siegfried's Sustainability Journey: Aligning Customer Engagement with Stakeholder Interests	9:00 AM - 9:30 AM
Luca Dalla Torre General Counsel Siegfried Holding AG
The Growing Importance CMC Consultants For Small Molecule Biotech	9:30 AM - 10:15 AM
Mike Spangler Principal Spangler Consulting Deb Minor President Drug Discovery Alliances Jim Bruno Principal Chemical and Pharmaceutical Solutions Mike Spangler Principal Spangler Consulting James Kanter Principal K2 CMC Sean Bradley Vice President of Business Development GL Chemtec International Ltd.
Navigating Sell-side M&A in the CDMO Industry: Tax, Financial, and Strategic Insights How to be Prepared to Sell your Company	10:15 AM - 11:15 AM
Jean-Jacques (John) Mondoloni Managing Partner Wombat Capital Johnny Montoya Tax Principal, Transaction Advisory Services BDO Jon Moore Director, Transaction Advisory Services BDO